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Abstract 1 
Thermal burn injuries in patients alcohol intoxicated result in greater morbidity and 2 
mortality.  Murine models combining ethanol and localized thermal burn injury 3 
reproduce the systemic toxicity seen in human subjects, which consists of both 4 
acute systemic cytokine production with multiple organ dysfunction, as well as a 5 
delayed systemic immunosuppression.  However, the exact mechanisms for these 6 
acute and delayed effects are unclear.  These studies sought to define the role of 7 
the lipid mediator Platelet-activating factor (PAF) in the acute and delayed effects 8 
of intoxicated burn injury.  Combining ethanol and thermal burn injury resulted in 9 
increased enzymatic PAF generation in a keratinocyte cell line in vitro, human skin 10 
explants ex vivo, as well as in murine skin in vivo.  Further, the acute increase in 11 
inflammatory cytokines such as IL-6, and the systemic immunosuppressive effects 12 
of intoxicated thermal burn injury, were suppressed in mice lacking PAF receptors.  13 
Together, these studies provide a potential mechanism and novel treatment 14 
strategies for the augmented toxicity and immunosuppressive effects of thermal 15 
burn injury in the setting of acute ethanol exposure, which involves the pleotropic 16 
lipid mediator PAF.   17 
 18 
19 
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Introduction 20 
Thermal burn injury causes significant morbidity and mortality.  More than 100,000 21 
patients are hospitalized in the U.S. annually for severe burn injuries (Choudry et 22 
al., 2006).  Ethanol use at the time of injury is found in almost half of burn patients, 23 
and this population is nearly twice as likely to suffer from morbid complications 24 
(Silver et al., 2008; Grobmyer et al., 1996; Haum et al., 1995; McGill et al., 1995; 25 
Davis et al., 2013; Friedmann, 2013; Howland et al., 1987).  The complications 26 
found in patients who had moderate to high blood ethanol levels at the time of the 27 
thermal burn injury include over 50% more surgical procedures, a doubling of the 28 
risk of severe infectious complications, and  length of inpatient hospitalization.  It 29 
should be noted that the majority of these intoxicated burn patients are not chronic 30 
alcoholics, but binge drinkers (McGill et al., 1995; Davis et al., 2013; Howland et 31 
al., 1987).  32 
Murine models have been used to characterize the acute inflammatory and 33 
immunosuppressive effects observed in humans (Faunce et al., 1997; Faunce et 34 
al., 1998; Faunce et al., 2003; Bird et al., 2008; Li et al., 2011; Chen et al., 2013).  35 
In particular, intoxicated burn injury results in an increased level of systemic 36 
cytokines with IL-6 being a key cytokine in these murine models.  IL-6 is elevated 37 
acutely in blood serum and peripheral organs including the lungs and small 38 
intestine. This IL-6 activation is believed to trigger both acute inflammation and 39 
longer term immunosuppressive effects as administration of anti-IL-6 antibodies 40 
can attenuate markers of acute pulmonary and gut associated inflammation as well 41 
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as delayed-type hypersensitivity immunosuppression associated with the 42 
intoxicated burn injury in mice (Li et al., 2011; Chen et al., 2013; Zahs et al., 2013).  43 
   44 
We believe there are several lines of evidence that support a causal role for the 45 
lipid mediator Platelet-activating factor (1-alkyl-2-acetyl-glycerophosphocholine; 46 
PAF [reviewed in (Palgan et al., 2015; Shimizu, 2009; Stafforini et al., 2003)] in this 47 
injury.  First, PAF, which acts through its specific ligand binding of a single G-48 
protein coupled receptor (PAF-R), contributes to systemic inflammatory syndromes 49 
from acute allergy response to septic shock, which are symptomatically similar 50 
acute findings found in intoxicated burn injury.  Second, PAF mediates systemic 51 
immunosuppression in response to many environmental stressors, including 52 
cigarette smoke exposure and ultraviolet B radiation (Waltersheid et al., 2002; 53 
Zhang et al., 2005; Wolf et al., 2006; Zhang et al., 2008; Sahu et al., 2013; 54 
Ferracini et al., 2015).  Third, thermal burn injury has been shown to generate PAF 55 
in keratinocytes (Alappatt et al., 2000).  Finally, we believe ethanol can promote 56 
PAF production as ethanol exposure has been demonstrated to increase the 57 
activity of phospholipase A2 (PLA2) enzymes (in particular cytosolic type IV 58 
[cPLA2]), which serve as a major enzyme for the remodeling pathway of PAF 59 
biosynthesis (Lee et al., 2004; Tajuddin et al., 2014).  Furthermore, a previous 60 
study has demonstrated that ethanol augments PAF biosynthesis in endothelial 61 
cells in response to ATP (Magai et al., 2001).  Subsequently, this study was 62 
designed to determine if there is a role for the PAF system in the acute pro-63 
inflammatory and delayed immunosuppressive effects of the intoxicated burn 64 
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injury.  We have found that intoxicated burn promotes PAF production in 65 
keratinocytes and that both the acute inflammatory cytokine production and the 66 
systemic immunosuppressive effects associated with this injury are suppressed in 67 
PAF-receptor deficient mice.  These results suggest a PAF-mediated mechanism 68 
for the morbidities associated with intoxicated injury, and point toward the PAF 69 
system as a novel therapeutic target for this all too frequent injury.  70 
Results  71 
Intoxicated burn injury results in increased PAF in a keratinocyte cell line.  Our 72 
previous in vitro studies have demonstrated that thermal burn injury stimulates 73 
enzymatic PAF biosynthesis (Alappatt et al., 2000).  Thus, our first experiments 74 
were designed to test the hypothesis that combining ethanol with thermal burn 75 
injury results in enhanced PAF biosynthesis.  For these studies, we used the 76 
human keratinocyte-derived cell line HaCaT (Boukamp et al., 1988).  As multiple 77 
glycerophosphocholines exert PAF-R agonistic effects (Marathe et al., 2001; 78 
Marathe et al., 2005), our first studies measured total PAF-R biochemical activity 79 
using the PAF-R-negative epidermoid cell line KB transduced with PAF-R (KBP) or 80 
control MSCV2.1 retrovirus (KBM) (Pet et al., 1998).  As shown in Figure 1, 81 
addition of complex lipid mixtures containing PAF-R agonists to KBP cells results in 82 
an immediate intracellular calcium (Ca2+) mobilization response, as well as delayed 83 
IL-8 production, both of which are useful methodologies to quantify PAF-R 84 
agonistic activity (Zhang et al., 2005; Sahu et al., 2013; Ferracini et al., 2015; Sahu 85 
et al., 2014).  Using this KBP-KBM model system, incubation of HaCaT 86 
keratinocytes with ethanol before thermal burn injury resulted in augmented PAF-R 87 
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agonist formation as documented by increased intracellular Ca2+ mobilization 88 
selectively in PAF-R-expressing KBP cells (Fig 1A,B) as well as IL-8 accumulation 89 
(Fig 1D) upon exposure to lipid extracts of the treated HaCaT keratinocytes.  90 
Similar to the Ca2+ mobilization studies, lipid extracts derived from HaCaT cells did 91 
not result in IL-8 release in PAF-R-negative KBM cells (Supplemental Fig S1).  92 
Testing various ethanol doses ranging from 0.25%-2% revealed that doses above 93 
1% combined with thermal burn injury resulted in the most PAF agonistic activity 94 
generated (Supplemental Fig S2).  Treatment of primary cultures of 95 
undifferentiated human keratinocytes with ethanol + thermal burn injury resulted in 96 
qualitatively similar findings of increased PAF agonistic activity generated as seen 97 
in HaCaT cells (see Supplemental Fig S3).   98 
     PAF-R agonists consist of both enzymatically produced sn-2 acetyl species as 99 
well as non-enzymatically generated sn-2 oxidatively modified species (Shimizu, 100 
2009; Marathe et al., 2001; Marathe et al., 2005; Sahu et al., 2014).  To define the 101 
exact species formed in response to combining ethanol + thermal burn injury, we 102 
employed mass spectrometry using deuterated internal standards as previously 103 
described (Sahu et al., 2014; Yao et al., 2012).  As shown in Figure 2 (for the major 104 
PAF species 1-hexadecyl-2-acetyl GPC and 1-octadecyl-2-acetyl GPC) and Table 105 
S1 in supplemental (for a total of eight different sn-2 GPC species), combining 106 
ethanol and thermal burn injury resulted in approximately 3-4 fold increase of these 107 
PAF species.  However, we did not detect increased levels of oxidized GPCs or 108 
PAF precursor lyso-PAF.  The PAF-R biochemical activity combined with the 109 
quantitative analysis of PAF-R agonists indicates that the PAF-R biochemical 110 
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activity resides in enzymatic sn-2 acetyl GPC (PAF) rather than non-enzymatic 111 
oxidized GPC.   112 
Ethanol activates phospholipase A2 and is incorporated into PAF.  To define the 113 
mechanism by which ethanol augments PAF biosynthesis, we tested whether or 114 
not the metabolism of ethanol impacts PAF production.  Using an alcohol 115 
dehydrogenase inhibitor (4-methylpyrazole; 4-MP) we found that 4-MP blocks PAF 116 
agonist formation in response to combining ethanol + thermal burn injury, but it had 117 
no discernable effects on PAF produced in response to thermal burn injury alone 118 
(Figure 3A).  This result suggests that ethanol metabolites mediate augmented 119 
PAF biosynthesis.  Ethanol can be metabolized to acetylCoA, which is the source 120 
of the sn-2 acetate in PAF (Shimizu, 2009; Snyder et al., 1996).  Therefore, we 121 
tested the hypothesis that the excess ethanol provides acetyl-CoA which is 122 
incorporated into newly synthesized PAF by incubating HaCaT cells with 123 
deuterium-labelled ethanol ([2,2,2-D3]-ethanol (99 atom% D).  Mass spectrometry 124 
was used to selectively assay the incorporation of the deuterium label into the PAF.  125 
Carbamoyl-PAF (CPAF) was used as the internal standard for the quantitation of 126 
the deuterium-labeled PAF. As shown in Supplementary Table S2, we were able to 127 
identify deuterium-labelled PAF (with three additional mass units).  However, the 128 
amount of deuterium-labelled PAF was only about 8% of total PAF produced 129 
following combined ethanol + thermal burn injury in HaCaT cells.  These results 130 
indicate that while the metabolism of ethanol enhances PAF production, only a 131 
small component of the PAF generated in response to combined ethanol + thermal 132 
burn injury is due to incorporation of ethanol-derived acetyl-CoA into PAF.   133 
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    PLA2 is a key enzyme for PAF biosynthesis in the remodeling pathway (Shimizu, 134 
2009).  As ethanol has been reported to activate PLA2 in several model systems 135 
(Lee et al., 2004; Tajuddin et al., 2014), we next tested the effects of thermal burn 136 
injury alone or in the presence of the ethanol on PLA2 activity in HaCaT cells.  As 137 
shown in Figure 3B, neither ethanol nor thermal burn injury treatment alone 138 
modulated PLA2 activity.  However, the combination of thermal burn injury with 139 
ethanol resulted in an increased PLA2 enzymatic activity.  Of interest, the level of 140 
PLA2 enzyme activity in response to thermal burn + ethanol resembled the potent 141 
stimulus (Balsinde et al., 1997) phorbol myristate acetate (PMA).  Consistent with 142 
our studies indicating that 4-MP blocked ethanol augmentation of PAF production, 143 
pretreatment with 4-MP blocked the ability of ethanol to augment PLA2 activity 144 
induced by thermal burn injury (Fig 3B).  Neither ethanol nor 4-MP pretreatment 145 
modulated PMA-induced PLA2 activity.  Moreover, none of these stimuli affected 146 
the activity of the PAF and Ox-GPC metabolizing enzyme PAF-acetylhydrolase in 147 
HaCaT cells (Supplementary Fig S4).  These results suggest that ethanol 148 
metabolism augments thermal burn injury-induced PAF production via PLA2 149 
activation using the PAF remodeling pathway.            150 
           151 
Combination of ethanol + thermal burn injury augments PAF generation in both 152 
murine and human skin.   The in vitro results in keratinocytes lead us to determine 153 
if an intoxicated burn injury could induce PAF production in intact skin tissue. Initial 154 
studies used a previously published murine model of intraperitoneal injection of 155 
400 ul of 20% ethanol (2.4 g/kg) followed 30 minutes later by thermal burn injury to 156 
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skin (Faunce et al., 1997; Faunce et al., 1998).  Anesthetized C57BL/6 mice were 157 
treated with saline or ethanol i.p., 30 minutes prior to a thermal burn injury of 158 
approximately 12-15% body surface area.  Immediately following the injury, lipids 159 
were extracted from the injured epidermis and tested for PAF-R agonistic activity 160 
using the KBP IL-8 assay (as in Fig 1).  Enhanced PAF-R agonist formation was 161 
observed in the combined ethanol + burn injury group relative to controls (Figure 162 
4A).  To similarly assess if ethanol + burn injury elevates PAF-R agonistic activity 163 
in human skin, we treated discarded human skin tissue from body contouring 164 
surgeries (e.g., abdominoplasties) with topical 20% ethanolic solution (or control) 1 165 
hour prior to a thermal burn injury using a 90 deg C heated metal block applied for 166 
8 seconds.  Similarly to the in vivo skin, the epidermal lipid extracts from the 167 
combined ethanol + thermal burn skin augmented PAF-R agonist formation relative 168 
to the thermal burn control.  Similar to our findings with HaCaT cells 169 
(Supplementary Fig S1), lipid extracts from skin specimens did not induce IL-8 in 170 
PAF-R-negative KBM cells (data not shown).  These studies demonstrate that 171 
ethanol augments murine and human epidermal PAF production in response to 172 
thermal burn injury. 173 
 174 
PAF-R activation mediates acute systemic inflammation in response to intoxicated 175 
burn injury.  Previous studies have demonstrated that intoxicated thermal burn 176 
results in an enhanced systemic inflammatory response (e.g. IL-6 activation), 177 
relative to controls (Faunce et al., 1997; Faunce et al., 1998; Faunce et al., 2003; 178 
Bird et al., 2008; Li et al., 2011; Chen et al., 2013; Zahs et al., 2013). Given our in 179 
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vitro and in vivo findings that ethanol + thermal burn injury augments PAF 180 
production, coupled with the well characterized role of PAF in mediating 181 
inflammatory responses (Shimizu 2009; Stafforini et al., 2003; Zhang et al., 2005), 182 
we sought to define the role of the PAF-R in the acute inflammatory response to 183 
intoxicated thermal burn injury.  Utilizing the wild-type or PAF-R-deficient (Ptafr-/-) 184 
mice (Ishii et al., 1998) we found (Figure 5) that ethanol exposure alone did not 185 
result in increased serum IL-6 levels in either genotype.  Moreover, thermal burn 186 
injury increased serum IL-6 levels in both PAF-R-positive and –negative mice, but 187 
the combination of ethanol + thermal burn injury triggered increased IL-6 levels 188 
above thermal burn injury alone only in PAF-R-expressing mice.  Serum was also 189 
assayed for 22 other inflammation-related cytokines using cytokine array, which 190 
not only confirmed our IL-6 findings, it revealed similar profiles of augmented levels 191 
of MIP-1β, MCP-1, G-CSF, and TNF-α in combined ethanol + thermal burn injury 192 
over thermal burn injury alone selectively in wild-type mice (see Supplemental 193 
Table S2).  These studies suggest that the acute systemic toxicity associated with 194 
murine thermal injury in the setting of ethanol intoxication involves PAF-R 195 
activation.       196 
     197 
PAF-R activation mediates the delayed immunosuppression associated with 198 
intoxicated thermal burn injury.  Combining ethanol and localized thermal burn 199 
injury in mice results in systemic immunosuppression as shown by decreasing 200 
contact hypersensitivity responses to the chemical dinitrofluorobenzene (DNFB) 201 
(Faunce et al., 1997; Faunce et al., 1998).  Of note, multiple environmental 202 
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stressors that trigger PAF agonist formation including ultraviolet B radiation 203 
(Walterscheid et al., 2002; Marathe et al., 2005), photodynamic therapy (Ferracini 204 
et al., 2015), chemotherapy (Sahu et al., 2014) and cigarette smoke (Sahu et al., 205 
2013) all induce systemic immunosuppression in a PAF-R-dependent manner.  206 
The next studies were designed to test if the combined ethanol + thermal burn 207 
injury immunosuppression is due to the enhanced skin PAF generation from this 208 
clinically-relevant combination.  To assess the effects of the injury on immune 209 
competence, Ptafr-/- and wild-type mice received an intoxicated thermal burn injury 210 
or control treatments and were then subjected to the well-established delayed-type 211 
hypersensitivity protocol (Zhang et al., 2005; Zhang et al., 2008; Ferracini et al., 212 
2015).  Briefly, five days after treatment, the mice were sensitized with the 213 
chemical DNFB topically applied to the shaved non-thermal burn-injured part of the 214 
upper back (to test for systemic immunosuppression) and challenged 9 days later 215 
with DNFB applied to the ears. The intensity of the immune response to DNFB was 216 
measured by change in the ear thickness prior to and 24 h after the delayed 217 
challenge.  Animals were also injected with PAF-R agonist CPAF or histamine as 218 
controls for PAF-dependent and independent immunosuppression, respectively.  219 
As shown in Figure 6, only the intoxicated burn injury of wild-type mice suppressed 220 
the delayed hypersensitivity response, suggesting that intoxicated burn-mediated 221 
immuno-suppression is PAF-R dependent.    222 
223 
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Discussion 224 
  Thermal burn injuries are commonly associated with ethanol intoxication, and the 225 
presence of ethanol results in a much poorer prognosis (Choudry et al., 2006; 226 
Silver et al., 2008; Grobmyer et al., 1996; Haum et al., 1995; McGill et al., 1995).  227 
In particular, the combination of acute ethanol intoxication followed by thermal burn 228 
injury in humans exhibit augmented systemic cytokine production, especially IL-6.  229 
Of interest, increased serum IL-6 levels are correlated with worse prognosis in 230 
patients (Bird et al., 2008; Albright et al., 2012).  Murine model systems combining 231 
systemic ethanol and thermal burn injury reproduce many of the pathologies seen 232 
in humans (Faunce et al., 1997; Faunce et al., 1998; Faunce et al., 2003; Bird et 233 
al., 2008; Li et al., 2011).  These include the systemic toxicity with inflammation 234 
associated with multiple organs (Bird et al., 2008; Li et al., 2011; Chen et al., 2013; 235 
Zahs et al., 2013).  In addition, murine studies have demonstrated that combining 236 
ethanol and localized thermal burn injury results in systemic immunosuppression 237 
(Faunce et al., 1997; Faunce et al., 1998).  Intoxication by intraperitoneal injection 238 
or oral gavage equally potentiates the organ damage and inflammation following 239 
thermal burn injury (Chen et al., 2013).  The exact mechanism of the acute effects 240 
is unclear, though neutralizing antibodies against IL-6 have been demonstrated to 241 
be protective (Faunce et al., 1998; Zahs et al., 2013).  One potential mechanism 242 
for the acute systemic injury of intoxicated burn injury involves facilitating intestinal 243 
permeability, causing the gut/liver axis to generate IL-6 (Zahs et al., 2012; Early et 244 
al., 2015).  It should be noted that PAF has been reported to augment gut 245 
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permeability (Tan et al., 2000; Akyürek et al., 2005; Keely et al., 2010), potentially 246 
providing a direct link between excess skin-generated PAF and systemic toxicity.   247 
  The present studies provide evidence that the lipid mediator PAF is involved in 248 
both the acute systemic cytokine production as well as the delayed 249 
immunosuppressive effects of ethanol + thermal burn injury.  PAF production in 250 
response to thermal burn injury in a keratinocyte cell line in vitro as well as human 251 
skin ex vivo and murine skin in vivo are all increased dramatically in response to 252 
short-term incubation with ethanol.  Use of PAF-R deficient mice confirm that the 253 
increased PAF being generated from skin in response to ethanol + thermal burn 254 
injury is involved in the systemic effects of this combination.   255 
  Unlike pro-oxidative stressors such as UVB which as our group has reported 256 
generates both enzymatic PAF and non-enzymatic oxidized 257 
glycerophosphocholines in keratinocytes (Marathe et al., 2005), our mass 258 
spectrometry-based structural studies indicate that the vast majority of the 259 
combination of ethanol and thermal burn injury-generated PAF is produced 260 
enzymatically.  PAF is synthesized enzymatically via two separate pathways 261 
(Shimizu, 2009).  The remodeling pathway which is associated with cellular 262 
stimulation from a variety of sources consists of PLA2 followed by an acetyl-CoA-263 
dependent acetyltransferase (LPCAT) that acetylates a lyso-PAF intermediate to 264 
form PAF.  A second pathway for PAF synthesis involves a de novo pathway, 265 
which consists of three separate enzymes:  1-alkyl-2-lyso-sn-glycero-3-phosphate 266 
(alkyllyso-GP): acetyl-CoA acetyltransferase, 1-alkyl-2-acetyl-sn-glycero-3-267 
phosphate phosphohydrolase, and 1-alkyl-2-acetyl-sn-glycerol (alkylacetyl-268 
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G):CDP-choline cholinephosphotransferase.  This de novo pathway appears to be 269 
more constitutively active, generating low levels of PAF, though it can be activated 270 
by phorbol esters (Shimizu, 2009; Snyder et al., 1996; Snyder, 1997).  It should be 271 
noted that keratinocytes use the remodeling pathway to synthesize PAF (Travers 272 
et al., 1996).  Consistent with the notion that ethanol augmentation of PAF 273 
biosynthesis involves the remodeling pathway, pretreatment of HaCaT cells with 274 
the LPCAT inhibitor TSI-01 at a dose that inhibits PAF production in A23187-275 
stimulated macrophages (Tarui et al., 2014), blocks PAF production in response to 276 
ethanol + thermal burn injury (Supplementary Figure S-5).  Of interest, TSI-01 277 
exerted only partial inhibitory effects on PAF-R agonist generation in response to 278 
treatment with tert-butyl hydroperoxide (Figure S-5), which confirms our previous 279 
studies that the majority of PAF-R agonists from this pro-oxidative stressor are due 280 
to non-enzymatic processes (Travers, 1999). 281 
  The present studies provide evidence that short-term ethanol exposure augments 282 
thermal burn injury-induced PAF biosynthesis through several mechanisms.  First, 283 
ethanol pre-incubation followed by thermal burn injury results in augmented PLA2 284 
enzymatic activity, yet ethanol alone has no effect.  These findings suggest 285 
involvement of PLA2 and thus the remodeling pathway.  The attenuating effects of 286 
LPCAT inhibitor TSI-01 also suggest involvement of the remodeling pathway.  The 287 
second, albeit minor mechanism that appears to be in play is suggested by our 288 
deuterated ethanol studies, which demonstrate a small amount of the PAF (~8%) is 289 
due to ethanol metabolized to acetyl-CoA.  Of interest, keratinocytes do express 290 
both alcohol dehydrogenase and aldehyde dehydrogenase enzymes, though at 291 
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lower amounts (~20%) than hepatocytes (Cheung et al., 1999).  Our finding that 292 
the alcohol dehydrogenase inhibitor 4-MP blocks the ethanol augmentation of both 293 
PAF production and PLA2 activation by thermal burn injury suggests that the effect 294 
of ethanol in this system is due to a down-stream metabolite.   295 
  Recent studies have implicated PAF agonists in chronic ethanol toxicity.  In 296 
particular, chronic ethanol administration in rats and mice results in increased 297 
levels of oxidized glycerophosphocholines and PAF in plasma (Yang et al., 2010; 298 
Liu et al., 2013).  Moreover, PAF-R-deficient mice are protected from chronic 299 
ethanol-mediated kidney damage (Latchoumycandane et al., 2015).  In these 300 
chronic ethanol models, non-enzymatic oxidized glycerophosphocholine PAF 301 
agonists appear to play important roles, whereas the present acute ethanol + 302 
thermal injury model involves enzymatic PAF agonists.     303 
  The enhanced toxicity of combining ethanol with thermal burn injury might not be 304 
a unique process.  Indeed, preclinical studies combining acute radiation + thermal 305 
burn injury were found to result in similar findings to ethanol + thermal burn injury 306 
(Palmer et al., 2013).  Given that radiation is a potent stimulus for PAF production 307 
(Sahu et al., 2016), it is possible that the PAF system could also be involved in this 308 
process.          309 
  Thermal burn injuries are a significant source of morbidity and mortality.  Ethanol 310 
intoxication at the time of the thermal burn injury is a relatively common 311 
occurrence, and is associated with poorer patient outcomes (Choudry et al., 2006; 312 
Silver et al., 2008; Grobmyer et al., 1996; Haum et al., 1995; McGill et al., 1995; 313 
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Davis et al., 2013).  The present studies provide a potential mechanism involving 314 
the PAF system for many of both the acute pro-inflammatory and delayed 315 
immunosuppressive effects associated with combining ethanol and thermal burn 316 
injury.  These findings could provide the impetus for novel therapies to address the 317 
enhanced morbidity and mortality associated with intoxicated burn patients.  318 
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Materials and Methods     319 
All chemicals were obtained from Sigma-Aldrich (St. Louis, MO) unless indicated 320 
otherwise.  HaCaT keratinocyte-derived cell line was grown in DMEM high glucose 321 
media with 10% FCS as described (Marathe et al., 2005). PAF-R-negative KB cells 322 
were rendered PAF-R-positive (KBP) by transducing the MSCV2.1 retrovirus 323 
encoding the human leukocyte PAF-R and PAF-R-deficient (KBM) by transducing 324 
with the vector alone and grown in DMEM high glucose media with supplements as 325 
described previously (Pei et al., 1998).  Cell lines were regularly tested for 326 
mycoplasma.  HaCaT cells were grown to approximately 80-90% confluence in 10 327 
cm dishes, and washed three times with Hanks Balanced Salt Solution (HBSS) and 328 
then incubated with 2 ml of pre-warmed (37 °C) HBSS  with 10mg/ml fatty acid-free 329 
BSA with/without 1% ethanol.   After 30 min, the cells were treated by placement 330 
onto a 90 oC water bath for two minutes.  In some experiments, 100 µM 4-MP was 331 
preincubated for 30 min before addition of ethanol +/- thermal burn injury.  The 332 
incubations were quenched by addition of 2 ml of ice-cold methanol followed by 333 
methylene chloride, and lipids extracted as described (Marathe et al., 2005; Yao et 334 
al., 2012).   335 
Mice 336 
Female C57BL/6-wild type mice (PAF-R expressing; age 6-8 week) were 337 
purchased from The Charles River Laboratories. Age-matched female PAFR-338 
deficient (Ptafr-/-) mice on a C57BL/6 background, generated as described (Isshi et 339 
al., 1998), were a kind gift of Professor Takao Shimizu (Department of 340 
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Biochemistry, University of Tokyo). All mice were housed under specific pathogen-341 
free conditions and all procedures were approved by the Institutional Animal Care 342 
and Use Committees of Indiana University School of Medicine and Wright State 343 
University.   344 
 345 
Calcium mobilization studies  346 
The presence of systemic PAF-R agonists in lipid extracts derived from HaCaT 347 
cells was assessed by the ability of lipid extracts to induce an intracellular Ca2+ 348 
mobilization response in FURA-2 AM-loaded PAF-R-expressing KBP cells, but not 349 
in PAFR-deficient KBM cells as described (Ferracini et al., 2015; Pei et al., 1998; 350 
Sahu et al., 2014).  PAF-R agonistic activity in lipid extracts was quantified by 351 
measuring IL-8 released into the supernatants of KBP vs KBM cells as reported 352 
(Ferracini et al., 2015; Sahu et al., 2014).  353 
 354 
Mass spectrometry studies  355 
Mass spectrometry was performed on HaCaT cell samples using the AB Sciex 356 
(Foster City, CA) triple quadrupole QTRAP® 5500 mass spectrometer, equipped 357 
with a CTC-PAL autosampler and a Shimadzu HPLC as described (Yao et al, 358 
2012; Sahu et al., 2014). In some experiments D3 Ethanol (>99% purity) from 359 
Sigma Aldrich was used instead of ethanol.   360 
PLA2/PAF-AH enzyme assays.   361 
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PLA2 and PAF-AH enzyme activity was measured in HaCaT cells using specific 362 
assays (Cayman Chemical, Inc) exactly as per manufacturer’s recommendations. 363 
Thermal burn injury in murine and human skin 364 
All procedures involving mice were approved by the Animal Care and Use 365 
Committees of Indiana University School of Medicine and Wright State University.  366 
Wild-type or Ptafr-/- C57BL/6J mice were anesthetized with ketamine/xylazine (100 367 
and 10mg/kg, respectively) and fur removed from dorsal back skin by shaving with 368 
clippers.  The mice were given 0.4ml of 20% ethanol (2.4g/kg) in distilled water or 369 
water alone.  Thirty minutes later, the dorsal skin of the mice were treated with 8 370 
second exposure of stainless steel metal heated to 90 oC.  Mice were then given 1 371 
ml of normal saline i.p. and buprimorphine i.m. To measure PAF-R agonists, 5 min 372 
post thermal burn injury burned skin from wild-type mice was treated with liquid 373 
nitrogen using a cryo-spray (Brymill, Inc., Ellington, CT).  The epidermal skin was 374 
curetted and the contents weighed before lipid extraction.  In experiments 375 
measuring acute serum cytokines or contact hypersensitivity studies, the mice 376 
were allowed to awaken.  In some experiments the mice were euthanized at 14h 377 
post injury and blood serum isolated and assayed for IL-6 by ELISA (R &D, 378 
Minneapolis, MN).  In some experiments multiple cytokines were assayed using a 379 
multiplex system (BioRad).  In other experiments, contact hypersensitivity studies 380 
were performed using dinitrofluorobenzene (DNFB) as previously described 381 
(Zhang et al., 2008; Sahu et al., 2013).  Briefly, mice were sensitized to 50 µl of 382 
DNFB on dorsal back skin at least 2 cm away from the burn site, five days post 383 
thermal burn injury.   Nine days later the mice were anesthetized and ear thickness 384 
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measured using Mitutuyo calipers.  20 µl DNFB was applied to one ear and 4:1 385 
acetone: olive oil applied to one ear.  24 h later the mice were anesthetized and 386 
ear thickness re-assessed.  In some experiments mice were not sensitized to 387 
DNFB yet treated with DNFB on ears as control.   388 
 389 
Human skin tissue 390 
De-identified skin was obtained from contouring surgeries (abdominoplasties and 391 
brachiplasties) (Travers et al., 2010; Fahy et al., 2017).  Patient consent for 392 
experiments was not required because our institutions consider de-identified 393 
human tissue left over from surgery as discarded material and thus the studies 394 
were exempt.  Skin was washed and fat trimmed, and placed at 37 oC  in PBS.  395 
Skin was treated with 20% ethanol in PBS, or PBS alone (100 µl per 2 x 2 cm 396 
area).   After one hour incubation, skin was treated with thermal burn injury with 397 
heated metal for 10 seconds as described for the murine studies.  After 5 min, skin 398 
was treated with liquid nitrogen with a Cryac, and epidermis curetted and weighed.  399 
The lipids were extracted (and normalized to 25 mg wet tissue) and PAF-R 400 
agonists quantified using IL-8 release in KBP vs KBM cells (Ferracini et al., 2015; 401 
Pei et al., 1998; Sahu et al., 2014).   402 
Statistics 403 
All statistical calculations were performed using Prism 6.  Statistical significance 404 
was determined between individual groups using student’s T-test, with significance 405 
listed as p <0.05.  406 
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Figure Legends. 
 
Figure 1.  EtOH exposure augments PAF-R agonistic activity in response to 
thermal burn injury in HaCaT cells.  HaCaT cells were subjected to 900C water 
bath x 2 min, or sham injury either under normal conditions or following a 30 min 
pre-incubation with 1% EtOH (BLUE).  Five min following injury treatment, the 
lipids were extracted and PAF-R agonistic activity assessed.  A,B).  Examples of 
PAF-R calcium mobilization assays.  PAF-R-expressing (A) KBP or (B) PAF-R-
negative KBM cells were loaded with Fura-2 AM, and treated with lipid extracts 
derived from 5 x 106 HaCaT cells, and CPAF or endothelin-1 (ET-1) used at the 
end of the assay as positive controls.  C,D).  Measurement of IL-8 release by KBP 
cells.  C) Model of KBP-IL-8 assay where a complex mixture (lipid extracts) 
containing PAF agonists are incubated with PAF-R-positive KBP cells and IL-8 
released used as surrogate of PAF-R activation. D) Lipid extracts from 5 x 106 
HaCaT cells previously treated with thermal injury ± ethanol or 1 nM CPAF as 
positive control were incubated with KBP cells and 6h later IL-8 measured in the 
supernatants as a surrogate for PAF-R activation.  The data are the Mean ± SE IL-
8 production in KBP cells (pg/106 KBP cells) from three separate experiments. 
*Denotes statistically significant (P<0.05) changes in levels of PAF-R agonistic 
activity from burn values w/o EtOH exposure.   
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Figure 2.  EtOH exposure + thermal burn injury results in augmented PAF 
species accumulation in HaCaT cells.  HaCaT cells were subjected to thermal 
burn injury (TBI) ± EtOH as outlined in Fig. 1.  Five min following injury treatment, 
the lipids were extracted and PAF species (1-octadecyl-2-acetyl-GPC [C-18 PAF] 
and hexadecyl-2-acetyl-GPC [C-16 PAF]) was quantified by mass spectrometry 
using deuterated internal standards.  The data are Mean ± SE PAF levels (pg/106 
HaCaT cells) from five separate experiments. *Denotes statistically significant 
(P<0.05) changes in levels of PAF from control (sham-treated) values; **Denotes 
statistically significant (P<0.05) changes in levels of PAF in comparison to burn w/o 
EtOH exposure.  
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Figure 3.  4-MP pretreatment blocks augmentation of EtOH on PAF-R agonist 
formation and PLA2 enzyme activity in response to thermal burn injury in 
HaCaT cells.  A.  PAF-R agonistic activity.  HaCaT cells were pretreated with 2 mM 
4-MP, or vehicle (SHAM) for 30 min before treatment with 1% EtOH (BLUE) for an 
additional 30 min.  Cells were then subjected to thermal burn injury (TBI), and 5 
min following injury the lipids were extracted and normalized to HaCaT cell 
number, and PAF-R agonistic activity determined as measurement of IL-8 released 
in KBP cells. The data are the Mean ± SD % control PAF-R agonists measured 
from IL-8 production in KBP cells (pg/106 KBP cells) from a single experiment 
representative of four separate experiments.  B. PLA2 enzymatic activity.  HaCaT 
cells were treated exactly as in A., except that 10nM PMA was also used.  The 
data are the Mean ± SE PLA2 enzymatic activity normalized to Sham Control 
values from 4-5 separate experiments.  *Denotes statistically significant (P<0.05) 
changes in levels of % IL-8 production or normalized PLA2 activity in comparison to 
sham values; ** Denotes statistically significant (P<0.01) changes in comparison to 
burn injury alone; # Denotes statistically significant (P<0.01) changes in 
comparison to EtOH + TBI.  ^ Denotes not significantly different from TBI. 
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Figure 4.  EtOH exposure augments PAF-R agonistic activity in response to 
thermal burn injury in murine skin in vivo and human skin ex vivo.  A. Murine 
skin. The dorsal back skin of groups of 5-6 anesthetized C57BL6 mice were 
subjected to thermal burn injury (8 second treatment with 900C heated iron blocks) 
or sham following a 30 min exposure to i.p. PBS vehicle or 2.4g/kg EtOH (BLUE). 
Five min following injury treatment to mice, the skin was harvested and lipids were 
extracted and normalized to 10mg weight of skin. B. Human skin. Human skin 
abdominoplasty specimens were pre-treated with topical 20% EtOH in PBS 
(BLUE) or PBS alone and 1h later treated with an 8 sec thermal burn injury or 
sham control as outlined in A.  Five min following thermal burn injury, skin was 
harvested and lipids extracted and normalized to 25mg weight of skin. PAF-R 
agonistic activity in both murine and human skin samples was assessed by 
measurement of IL-8 release in KBP cells as in Fig 1. The data are A. Mean ± SD 
IL-8 production in KBP cells (pg/106 KBP cells) from 5-6 mice in each group, and 
B. Mean ± SE % control human skin PAF-R agonistic activity from four separate 
experiments. *Denotes statistically significant (P <0.05) changes in levels of PAF-R 
agonist activity from control values w/o EtOH exposure.  
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Figure 5.  EtOH exposure augments serum IL-6 levels in response to thermal 
burn injury in a PAF-R-dependent manner.  Wild-type or PAF-R-deficient  
(Ptafr-/-) mice underwent treatment with either vehicle or EtOH, then 30 min later 
subjected to TBI or Sham treatment.  14 h later mice were harvested and serum 
levels of IL-6 measured by ELISA.  The data represent Mean ± SD IL-6 from a total 
of 6-8 mice in each group. *Denotes statistically significant (P<0.05) changes in 
levels of IL-6 from sham values; ** Denotes statistically significant (P<0.05) 
changes in comparison to burn injury alone; # Denotes no statistically significant 
changes in comparison to TBI alone. 
 
Figure 6.  Thermal burn injury results in enhanced immunosuppression when 
combined with EtOH in a PAF-R-dependent manner. Wild-type or PAF-R-
deficient (Ptafr-/-) mice underwent treatment with either vehicle or EtOH, then 30 
min later subjected to TBI or Sham treatment.  Some mice were treated with 250ng 
CPAF i.p. or 200 µg Histamine s.c. as positive controls for inhibition of contact 
hypersensitivity reactions to allergen DNFB (systemic immunosuppression).  Five 
days later the mice were sensitized on non-injured back skin with DNFB, and 9 
days later ear elicitation reactions to DNFB were obtained.  The data are the Mean 
± SD % change in ear thickness of the elicitation reactions obtained from sham-
treated animals using 7-10 mice in each group.  *Denotes significant (p <0.05) 
differences between value compared to sham control.  Please note only Histamine 
treatment resulted in an inhibition of CHS reactions to DNFB in Ptafr-/- mice. 
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